Poseida Therapeutics, Inc. (PSTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.9600 |
| Open | 1.9500 |
| Bid | 1.9200 x 1100 |
| Ask | 2.1500 x 2200 |
| Day's range | 1.9000 - 1.9800 |
| 52-week range | 1.5400 - 8.8200 |
| Volume | |
| Avg. volume | 964,783 |
| Market cap | 180.707M |
| Beta (5Y monthly) | 0.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0500 |
| Earnings date | 08 Nov 2023 - 13 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.80 |
Simply Wall St.Institutional investors may adopt severe steps after Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) latest 13% drop adds to a year losses
Key Insights Significantly high institutional ownership implies Poseida Therapeutics' stock price is sensitive to their...
- Simply Wall St.
News Flash: Analysts Just Made An Upgrade To Their Poseida Therapeutics, Inc. (NASDAQ:PSTX) Forecasts
Poseida Therapeutics, Inc. ( NASDAQ:PSTX ) shareholders will have a reason to smile today, with the analysts making...
ZacksPoseida Therapeutics, Inc. (PSTX) Reports Q2 Loss, Tops Revenue Estimates
Poseida Therapeutics, Inc. (PSTX) delivered earnings and revenue surprises of 39.62% and 100.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
